Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jan Aagaard
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersen, P. V
Right arrow Articles by Aagaard, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Andersen, P. V
Right arrow Articles by Aagaard, J.
Asian Cardiovasc Thorac Ann 2000;8:11-14
© 2000 Asia Publishing EXchange Pte Ltd


ORIGINAL CONTRIBUTION

Low-Dose Warfarin in Patients With Carbomedics Heart Valve Prostheses

Per V Andersen, MD, Jan Aagaard, MD

Department of Cardiothoracic and Vascular Surgery
Odense University Hospital
Odense, Denmark
For reprint information contact: Jan Aagaard, MD Tel: 45 6541 1853 Fax: 45 6591 6935 email: jan.aagaard{at}ouh.dk Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense C, DK-5000, Denmark.
All patients who received a Carbomedics heart valve prosthesis were assessed retrospectively by interview regarding thromboembolic, hemorrhagic, or other valve-related events. In cases of such events, the patient's practitioner or cardiologist was interviewed. Hospital records were reviewed in cases of hospital admission. Included in the study were patients who had isolated replacement of the aortic or mitral valve in whom it was possible to collect all International Normalized Ratio values from discharge through follow-up. There were 148 patients with isolated aortic valve replacement and 56 with isolated mitral valve replacement. Bleeding events were 3 times more frequent than thromboembolic events. Based on our results we will apply an International Normalized Ratio between 2 and 2.5 for patients with a Carbomedics heart valve prosthesis in aortic position and ratios between 2.5 and 3 for those with a mitral valve prosthesis.




This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
V. Pengo, G. Palareti, U. Cucchini, M. Molinatti, R. Del Bono, F. Baudo, A. Ghirarduzzi, C. Pegoraro, and S. Iliceto
Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)
Clinical and Applied Thrombosis/Hemostasis, July 1, 2007; 13(3): 241 - 248.
[Abstract] [PDF]


Home page
CMAJHome page
N. Oake, D. A. Fergusson, A. J. Forster, and C. van Walraven
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis
Can. Med. Assoc. J., May 22, 2007; 176(11): 1589 - 1594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by the Asia Publishing EXchange Ltd.